Red Light Holland Announces Closing of Final Tranche of Fully Subscribed Private Placement Including Strategic Mutual Investment with PharmaDrug

– July 16, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has closedContinue reading “Red Light Holland Announces Closing of Final Tranche of Fully Subscribed Private Placement Including Strategic Mutual Investment with PharmaDrug”

Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board

PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the “Company” or “PharmaDrug“) is pleased to announce that it has appointed global cannabis industry pioneer and founder of Aurora Cannabis Inc. (NYSE: ACB) (“Aurora“), Terry Booth, as the Chairman of its advisory board focussing on the Company’s psychedelic business. Mr. Booth has over 27 years of experience in tightly regulatedContinue reading “Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board”

FSD Pharma Monetizes Non-Core Asset With Sale of Partial Equity Stake in Pharmadrug Inc.

Buyer Holds Option to Purchase Additional Shares – TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) (“FSD Pharma” or the “Company”) today announced the sale of 5.0 million common shares of Pharmadrug Inc. (CSE:BUZZ) (formerly Aura Health) in a privately negotiated transaction at C$0.08 per share for cash proceeds of C$400,000. Under the terms of the sale,Continue reading “FSD Pharma Monetizes Non-Core Asset With Sale of Partial Equity Stake in Pharmadrug Inc.”